Pediatric obesity: Impact and surgical management

Southern Medical Journal

Volumn 99, Issue 8, 2006, Pages 833-845

  Pohl, John F ^a,b   Stephen, Matthew ^a   Wilson, Don P ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Bariatric surgery; Hyperlipidemia; Hypertension; Overweight; Pediatric obesity; Weight loss

Indexed keywords

SIBUTRAMINE;

BARIATRIC SURGERY; CHILDHOOD DISEASE; COMORBIDITY; DIET THERAPY; HUMAN; OBESITY; REVIEW; TREATMENT FAILURE; UNITED STATES; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; CHILD; DECISION MAKING; HUMANS; INCIDENCE; OBESITY; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; UNITED STATES;

EID: 33747165594     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000220890.29515.f0     Document Type: Review

References (110)

1. National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov. Accessed December 20, 2005.
2. Klish W. Childhood obesity. Pediatr Rev 1998;19:312-315.
3. Schwimmer JB. Childhood obesity: the case for coverage. Harvard Health Rev Policy 2003;4:62-72.
4. Hoelscher DM, Day RS, Lee ES, et al. Measuring the prevalence of overweight in Texas schoolchildren. Am J Public Health 2004;94:1002-1008.
5. Krude H, Biebermann H, Gruters A. Mutations in the human proopiomelanocortin gene. Ann N Y Acad Sci 2003;994:233-239.
6. Jahns L, Siega-Riz AM, Popkin BM. The increasing prevalence of snacking among US children from 1977 to 1996. J Pediatr 2001;138:493-498.
7. Slyper AH. The pediatric obesity epidemic: causes and controversies. J Clin Endocrinol Metab 2004;89:2540-2547.
8. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292:927-934.
9. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related co-morbidities. J Clin Endocrinol Metab 2004;89:2590-2594.
10. Pohl JH, Greer JA, Hasan KS. Type 2 diabetes mellitus in children. Endocr Pract 1998;4:413-416.
11. Centers for Disease Control and Prevention; Council of State and Teritorial Epidemiologists; Association of State and Territorial Chronic Disease Program Directors. Indicators of chronic disease surveillance. MMWR 2004;53:1-6.
12. Ribeiro JC, Guerra S, Oliveira J, et al. Body fatness and clustering of cardiovascular disease risk factors in Portuguese children and adolescents. Am J Hum Biol 2004;16:556-562.
13. Williams CL, Strobino B, Bollella M, et al. Body size and cardiovascular risk factors in a preschool population. Prev Cardiol 2004;7:116-121.
14. Steinberger J, Moran A, Hong CP, et al. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 2001;138:469-473.
15. Sorof JM, Lai D, Turner J, et al. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004;113:475-482.
16. Iannuzzi A, Licenziati M, Acampora C, et al. Preclinical changes in the mechanical properties of abdominal aorta in obese children. Metabolism 2005;53:1243-1246.
17. Ohta T, Saku K, Nakamura R, et al. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels. Atherosclerosis 1998;137:321-328.
18. Ford ES, Galuska DA, Gillespie C, et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001;138:486-492.
19. Barbeau P, Litaker MS, Woods KF, et al. Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. J Pediatr 2002;141:415-420.
20. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374.
21. Gidding SS, Nehgme R, Heise C, et al. Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. J Pediatr 2004;144:766-769.
22. Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children: American Academy of Pediatrics Committee on Native American Child Health. Pediatrics 2003;112:e328.
23. Wiegand S, Maikowski U, Blankenstein O, et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity: a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004;151:199-206.
24. Eberle D, Clement K, Meyre D, et al. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 2004;53:2153-2157.
25. Assy N, Kaita K, Mymin D, et al. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000;45:1929-1934.
26. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000;136:727-733.
27. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
28. Dixon JB, Bhathal PS, O'Brein PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
29. Cortez-Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999;282:1659-1664.
30. Schwimmer J, Deutsch R, Rauch J, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-505.
31. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
32. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-738.
33. Vajro P, Franzese A, Valerio G, et al. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 2000;136:739-743.
34. Barlow S, Dietz WH, Klish WJ, et al. Medical evaluation of overweight children and adolescents: report from pediatricians, pediatric nurse practitioners, and registered dieticians. Pediatrics 2002;110:222-228.
35. Poussa M, Schlenzka D, Yrjonen T. Body mass index and slipped capital femoral epiphysis. J Pediatr Orthop B 2003;12:369-371.
36. Goulding A, Taylor RW, Jones IE, et al. Overweight and obese children have low bone mass and area for their weight. Int J Obes Relat Metab Disord 2000;24:627-632.
37. Nicolai RD, Grasemann H, Oberste-Berghaus C, et al. Serum insulin-like growth factors IFG-1 and IGFBP-3 in children with slipped capital femoral epiphysis. J Pediatr Orthop B 1999;8:103-106.
38. Jingushi S, Suenaga E. Slipped capital femoral ephiphysis: etiology and treatment. J Orthop Sci 2004;9:214-219.
39. Bonuck KA, Kahn R. Prolonged bottle use and its association with iron deficiency anemia and overweight: a preliminary study. Clin Pediatr 2002;41:603-607.
40. Pinhas-Hamiel O, Newfield RS, Koren I, et al. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 2003;27:416-418.
41. Nead KG, Halterman JS, Kaczorowski JM, et al. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004;114:104-108.
42. Gunnbjornsdottir MI, Omenaas E, Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004;24:116-121.
43. Reade EP, Whaley C, Lin JJ, et al. Hypopnea in pediatric patients with obesity hypertension. Pediatr Nephrol 2004;19:1014-1020.
44. Ng DK, Lam YY, Kwok KL, et al. Obstructive sleep apnoea and obesity in children. Hong Kong Med J 2004;10:44-48.
45. Wing YK, Hui SH, Pak WM, et al. A controlled study of sleep related disordered breathing in obese children. Arch Dis Child 2003;88:1043-1047.
46. Mitchell RB, Kelly J. Adenotonsillectomy for obstructive sleep apnea in obese children. Otolaryngol Head Neck Surg 2004;131:104-108.
47. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-174.
48. Adelman RD, Restaino IG, Alon US, et al. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001;138:481-485.
49. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
50. Ross JA, Oeffinger KC, Davies SM, et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004;22:3558-3562.
51. Gascon F, Valle M, Martos R, et al. Childhood obesity and hormonal abnormalities associated with cancer risk. Eur J Cancer Prev 2004;13:193-197.
52. Wake M, Salmon L, Waters E, et al. Parent-reported health status of overweight and obese Australian primary school children: a cross-sectional population survey. Int J Obes Relat Metab Disord 2002;26:717-724.
53. Friedlander SL, Larkin EK, Rosen CL, et al. Decreased quality of life associated with obesity in school-aged children. Arch Pediatr Adolesc Med 2003;157:1206-1211.
54. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003;289:1813-1819.
55. Yanovski JA. Intensive therapies for pediatric obesity. Pediatr Clin North Am 2001;48:1041-1053.
56. Agras WS, Hammer LD, McNicholas F, et al. Risk factors for childhood overweight: a prospective study from birth to 9.5 years. J Pediatr 2004;145:20-25.
57. Viner RM, Cole TJ. Television viewing in early childhood predicts adult body mass index. J Pediatr 2004;147:429-435.
58. Patrick H, Nicklas TA. A review of family and social determinants of children's eating patterns and diet quality. J Am Coll Nutr 2005;24:83-92.
59. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med 2004;164:249-258.
60. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-1732.
61. Epstein LH, Valoskia A, Wing RR, et al. Ten-year outcomes of behavioral family-base treatment of childhood obesity. Health Psychol 1994;13:373-383.
62. Fitzgibbon ML, Stolley MR, Schiffer L, et al. Two-year follow-up results for Hip-Hop to Health Jr: a randomized controlled trial for overweight prevention in preschool minority children. J Pediatr 2005;146:618-625.
63. Dietz WH, Robinson TN. Overweight children and adolescents. N Engl J Med 2005;352:2100-2109.
64. Devaney B. What are infants and toddlers eating? Pediatrics 2004;144(Suppl):1156-1158.
65. Berkowitz RI, Wadden TA, Tershakovec AM, et al. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003;289:1805-1812.
66. Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture: the first double-blind placebo-controlled pilot study in adolescents. Int J Obes Relat Metab Disord 2000;24:1573-1578.
67. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res 2002;10:642-650.
68. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 1999;135:162-168.
69. Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001;50:1457-1461.
70. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:E55.
71. McDuffie JR, Calis KA, Booth SL, et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814-822.
72. Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005;353:2111-2120.
73. Sothern MS, von Almen TK, Schumacher HD, et al. A multidisciplinary approach to the treatment of childhood obesity. Del Med J 1999;71:255-261.
74. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547-559.
75. American Society of Bariatric Surgery. Available at: http://www.asbs.org. Accessed December 20, 2005.
76. Soper RT, Mason EE, Printen KJ, et al. Gastric bypass for morbid obesity in children and adolescents. J Pediatr Surg 1975;10:51-58.
77. Anderson AE, Soper RT, Scott DH. Gastric bypass for morbid obesity in children and adolescents. J Pediatr Surg 1980;15:876-881.
78. Inge TH, Zeller M, Garcia VF, et al. Surgical approach to adolescent obesity. Adolesc Med Clin 2004;15:429-453.
79. Brolin RE. Gastric bypass. Surg Clin North Am 2001;81:1077-1095.
80. Horgan S, Holterman MJ, Jacobsen GR, et al. Laparscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the United States: a safe alternative to gastric bypass. J Pediatr Surg 2005;40:86-91.
81. Garcia VF, Langford L, Inge TH. Application of laparascopy for bariatric surgery in adolescents. Curr Opin Pediatr 2003;15:248-255.
82. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114:217-223.
83. Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003;7:102-8.
84. Stanford A, Glascock JM, Eid GM, et al. Laparoscopic Roux-En-Y gastric bypass in morbidly obese adolescents. J Pediatr Surg 2003;38:430-433.
85. Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adolescent morbid obesity. J Pediatr 2001;138:499-504.
86. Rand CS, MacGregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J 1994;87:1208-1213.
87. Dolan K, Creighton L, Hopkins G, et al. Laparoscopic gastric banding in morbidly obese adolescents. Obes Surg 2003;13:101-104.
88. Widhalm K, Dietrich S, Prager G. Adjustable gastric banding surgery in morbidly obese adolescents: experiences with eight patients. Int J Obes Relat Metab Disord 2004;28 Suppl 3:S42-S45.
89. Abu-Abeid S, Gavert N, Klausner JM, et al. Bariatric surgery in adolescence. J Pediatr Surg 2003;38:1379-1382.
90. Haynes B. Creation of a bariatric surgery program for adolescents at a major teaching hospital. Pediatr Nurs 2005;31:21-22.
91. Cutland Laura. Hospitals chasing bariatric surgery business. Silicon Valley/San Jose Business Journal July 8, 2005.
92. Henry LL. Childhood obesity: what can be done to help today's youth? Pediatr Nurs 2005;31:13-16.
93. Rodgers BM, American Pediatric Surgical Association. Bariatric surgery for adolescents: a view from the American Pediatric Surgical Association. Pediatrics 2004;114:255-256.
94. Wittgrove AC, Buchwald H, Sugarman H, et al. Surgery for severely obese adolescents: further insight from the American Society of Bariatric Surgery. Pediatrics 2004;114:253-254.
95. Barlow SE. Bariatric surgery in adolescents: for treatment failures or health care system failures? Pediatrics 2004;114:252-253.
96. Inge TH, Donnelly LF, Vierra M, et al. Managing bariatric patients in a children's hospital: radiologic considerations and limitations. J Pediatr Surg 2005;40:609-617.
97. Marcason W. What are the dietary guidelines following bariatric surgery? J Am Diet Assoc 2004;104:487-488.
98. Elkins G, Whitfield P, Marcus J, et al. Noncompliance with behavioral recommendations following bariatric surgery. Obes Surg 2005;15:546-551.
99. Das SK, Roberts SB, McCrory MA, et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am J Clin Nutr 2003;78:22-30.
100. Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005;15:145-154.
101. Moize V, Geliebter A, Gluck ME, et al. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg 2003;13:23-28.
102. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005;353:249-254.
103. Livingston EH, Fink AS. Quality of life: cost and future of bariatric surgery. Arch Surg 2003;138:383-388.
104. Livingston EH. Hospital costs associated with bariatric procedures in the United States. Am J Surg 2005;190:816-820.
105. Sampalis JS, Liberman M, Auger S, et al. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg 2004;14:939-947.
106. Monk JS, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass. Obes Surg 2004;14:13-15.
107. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416-424.
108. van Hout GC, Verschure SK, van Heck GL. Psychosocial predictors of success following bariatric surgery. Obes Surg 2005;15:552-560.
109. 3-36. N Engl J Med 2003;349:941-948.
110. Strong WB, Malina RM, Blimkie CJ, et al. Evidence based physical activity for school-age youth. J Pediatr 2005;146:732-737.